10 The results from various studies indicated that incretin-based therapies such as exenatide, liraglutide, and semaglutide were able to improve clinical outcomes through decreasing neuroinflammation, increasing neuroprotection, and enhancing cognition
The orphan receptor GPR55 is a novel cannabinoid receptor
3 Medller tiroid kanseri geirmi veya ailesinde bu hastalk yks bulunan bireyler Hamile bireyler veya hamile kalmaya alan bireyler oklu endokrin neoplazisi olan veya ailesinde bu hastalk yks bulunan bireyler Emziren bireyler Ayrca, baz GLP-1 agonistleri, barsaklar etkileyen gastroparezi gibi salk sorunlar bulunan bireyler veya belirli bbrek hastalklarna sahip bireyler iin uygun olmayabilir
20 In agreement with the ADA, the American Association of Clinical Endocrinologists (AACE) lists DPP-4 inhibitors as an alternative in patients with an A1C under 7.5% in whom the use of metformin is contraindicated
Steve Small: Yeah, thats super handy